Visceral Leishmaniasis Treatment Outcome and Associated Factors in Northern Ethiopia

Table 1

Demographic and disease related characteristics of VL patients in ACSH, Tigray Region, Northern Ethiopia, June 2016–April 2018.

Variable	Category	Frequency (%)
Gender	Female	8 (5.4)
	Male	140 (94.6)
Age in years	18-35	94 (63.5)
	36-50	42 (28.4)
	>50	12 (8.1)
	Mean ± SD	32 ± 11.939
Residence	Rural	136 (91.9)
	Urban	12 (8.1)
Treatment History	New case	113 (76.4)
	Previously treated	35 (23.6)
Duration prior to diagnosis; (weeks)	< 2	42 (28.4)
	2-4	52 (35.1)
	> 4	54 (36.5)
Presence of signs and symptoms
Fever	Yes	100 (100)
Body weakness	Yes	124 (83.8)
	No	24 (16.2)
Epistaxis	Yes	23 (15.5)
	No	125 (84.5)
Weight loss	Yes	148 (100)
Loss of appetite	Yes	148 (100)
Diarrhea	Yes	15 (10.1)
	No	132 (89.2)
Splenomegaly	Yes	145 (98)
Lymphadenopathy	No	03 (2.0)
	Yes	06 (4.1)
Anemia	Yes	142 (95.9)
	No	06 (4.1)
Leucopenia	Yes	139 (93.9)
	No	09 (6.1)
Thrombocytopenia	Yes	125 (84.5)
	No	23 (15.5)
Method of diagnosis
Serologic (rk39 dipstick)	Positive	148 (100)
splenic aspirate result	Positive	110 (74.3)
	Negative	01 (0.7)
	Not done	37 (25)
Concomitant infection
TB	Yes	36 (24.3)
	No	112 (75.7)
HIV Status	Positive	31 (20.9)
	Negative	117 (79.1)
HIV and TB coinfection	Yes	15 (10.1)
	No	133 (89.9)
Malaria	Yes	40 (27)
	No	108 (73)